Medical Properties Trust, Inc. (NYSE:MPW) Position Cut by Wealthcare Advisory Partners LLC

Wealthcare Advisory Partners LLC lowered its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 4.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,215 shares of the real estate investment trust’s stock after selling 530 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Medical Properties Trust were worth $200,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Lenox Wealth Advisors LLC acquired a new stake in Medical Properties Trust during the third quarter valued at $31,000. Cullen Frost Bankers Inc. grew its position in Medical Properties Trust by 70.9% during the second quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 760 shares during the period. Manchester Financial Inc. acquired a new stake in Medical Properties Trust during the second quarter valued at $33,000. Cascade Investment Advisors Inc. purchased a new position in Medical Properties Trust during the second quarter valued at $35,000. Finally, Bessemer Group Inc. lifted its holdings in Medical Properties Trust by 597.5% during the second quarter. Bessemer Group Inc. now owns 3,020 shares of the real estate investment trust’s stock valued at $53,000 after purchasing an additional 2,587 shares in the last quarter. Hedge funds and other institutional investors own 71.66% of the company’s stock.

Several equities analysts have issued reports on the stock. ValuEngine downgraded shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Tuesday, November 5th. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research note on Wednesday, October 16th. Stifel Nicolaus set a $21.00 price target on shares of Medical Properties Trust and gave the stock a “buy” rating in a research note on Monday, August 12th. Barclays set a $22.00 price target on shares of Medical Properties Trust and gave the stock a “buy” rating in a research note on Monday, October 21st. Finally, Berenberg Bank assumed coverage on shares of Medical Properties Trust in a research note on Thursday, September 12th. They issued a “buy” rating and a $22.00 price target on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $20.18.

Shares of MPW traded up $0.53 during trading on Friday, reaching $19.95. 16,826,344 shares of the company traded hands, compared to its average volume of 4,039,835. The company has a quick ratio of 8.00, a current ratio of 6.27 and a debt-to-equity ratio of 1.02. The stock has a market cap of $8.56 billion, a PE ratio of 14.56, a price-to-earnings-growth ratio of 3.39 and a beta of 0.52. The stock has a 50-day simple moving average of $19.84 and a 200-day simple moving average of $18.53. Medical Properties Trust, Inc. has a twelve month low of $15.25 and a twelve month high of $20.92.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.12). Medical Properties Trust had a net margin of 41.57% and a return on equity of 6.36%. The business had revenue of $224.70 million during the quarter, compared to analyst estimates of $221.40 million. During the same quarter last year, the firm posted $0.35 EPS. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. On average, equities research analysts predict that Medical Properties Trust, Inc. will post 1.32 EPS for the current year.

In other news, CEO Edward K. Aldag, Jr. sold 101,964 shares of the business’s stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $19.78, for a total transaction of $2,016,847.92. Following the completion of the sale, the chief executive officer now owns 2,058,820 shares in the company, valued at approximately $40,723,459.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Emmett E. Mclean sold 100,000 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the sale, the insider now owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The disclosure for this sale can be found here. Insiders sold 279,464 shares of company stock valued at $5,359,673 in the last quarter. 1.18% of the stock is owned by insiders.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Story: Short Selling

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.